NCT03464058View on ClinicalTrials.gov

Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

October 9, 2018

Study Completion Date

October 10, 2018

Conditions
Healthy Subjects
Interventions
DRUG

BOS172767 tablets

Oral tablets

DRUG

BOS172767 liquid capsules

Oral capsules

DRUG

BOS172767 micronized capsules

Oral capsules

DRUG

BOS172767 immediate release capsules

Oral capsules

DRUG

BOS172767 matching placebo capsules

Oral capsules

DRUG

BOS172767 matching placebo tablets

Oral tablets

DRUG

Rabeprazole

Oral tablets

Trial Locations (1)

Unknown

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Boston Pharmaceuticals

INDUSTRY